Products 170569-88-7

CAS 170569-88-7 appears in our catalog under these names: Mavacoxib, 95%, Mavacoxib/ 99.36% (existing batch purity), Mavacoxib, Mavacoxib 95%, Mavacoxib, 99.04%. Offered by: Combi-blocks, TargetMol, GLPBio, Ambeed, MedChemExpress. Available pack sizes: 100mg, 5mg, 10mg, 25mg, 50mg, 200mg, 10mM (in 1ml dmso), 250mg.

Mavacoxib, 95%
Combi-blocks
  • size: 100mg
  • Variants: 1
View product
Mavacoxib/ 99.36% (existing batch purity)
TargetMol
  • size: 5mg, 10mg, 25mg, 50mg
  • Variants: 6
from 386.15
View product
Mavacoxib
GLPBio
  • size: 10mg, 25mg, 5mg, 10mM (in 1ml dmso)
  • Variants: 5
from 639.16
View product
Mavacoxib 95%
Ambeed
  • size: 25mg, 50mg, 100mg, 250mg
  • Variants: 4
from 181.25
View product
Mavacoxib, 99.04%
MedChemExpress
  • size: 10 mg, 25 mg, 50 mg, 5 mg
  • Variants: 6
from 328.98
View product
Mavacoxib (Standard)
MedChemExpress
  • size: Get quote
  • Variants: 1
View product
MAVACOXIB, >=99%
Fluorochem
  • size: 25mg, 10mg, 50mg
  • Variants: 3
from 180.16
View product
Structural formula: {0} (CAS {1})

Mavacoxib is a member of the class of pyrazoles that is 1H-pyrazole which is substituted at positions 1, 3 and 5 by 4-sulfamoylphenyl, trifluoromethyl and 4-fluorophenyl groups, respectively. A selective cyclooxygenase 2 inhibitor, it is used in veterinary medicine to treat pain and inflammation in dogs with degenerative joint disease. It has a role as a non-steroidal anti-inflammatory drug, a non-narcotic analgesic and a cyclooxygenase 2 inhibitor. It is a member of pyrazoles, a sulfonamide and an organofluorine compound.

Source: ChEBI

Identity
Molecular formulaC16H11F4N3O2S
Molecular weight385.3 g/mol
IUPAC name4-[5-(4-fluorophenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide
InChIKeyTTZNQDOUNXBMJV-UHFFFAOYSA-N
SMILESC1=CC(=CC=C1C2=CC(=NN2C3=CC=C(C=C3)S(=O)(=O)N)C(F)(F)F)F

Computed by PubChem (NCBI)

Synonyms: Mavacoxib, Trocoxil, 4-(5-(4-Fluorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide, mavacoxibum, 4-[5-(4-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide, 4-[5-(4-fluorophenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide, Mavacoxib (USAN), Mavacoxib [USAN], 4-[5-(4-Fluoro-phenyl)-3-trifluoromethyl-pyrazol-1-yl]-benzenesulfonamide, Benzenesulfonamide, 4-(5-(4-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)-